[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Human Blood Products Market Growth (Status and Outlook) 2022-2028

September 2022 | 86 pages | ID: G55B62990F73EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global market for Human Blood Products is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Human Blood Products market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Human Blood Products market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Human Blood Products market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Human Blood Products market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Human Blood Products players cover CSL, Octapharma AG, Kedrion SpA, Mitsubishi Tanabe Pharma Corporation and Takeda, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global Human Blood Products market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Human Blood Products market, with both quantitative and qualitative data, to help readers understand how the Human Blood Products market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:

The study segments the Human Blood Products market and forecasts the market size by Type (Platelets, Fresh Frozen Plasma and Red Blood Cells), by Application (Hospital, Blood Station and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
  • Platelets
  • Fresh Frozen Plasma
  • Red Blood Cells
  • White Blood Cells
  • Others
Segmentation by application
  • Hospital
  • Blood Station
  • Others
Segmentation by region
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Major companies covered
  • CSL
  • Octapharma AG
  • Kedrion SpA
  • Mitsubishi Tanabe Pharma Corporation
  • Takeda
  • Baxter
  • Grifols
  • Hualan Bio
  • BPL
Chapter Introduction

Chapter 1: Scope of Human Blood Products, Research Methodology, etc.

Chapter 2: Executive Summary, global Human Blood Products market size and CAGR, Human Blood Products market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: Human Blood Products revenue, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global Human Blood Products revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global Human Blood Products market size forecast by region, by country, by type, and application

Chapter 13: Comprehensive company profiles of the leading players, including CSL, Octapharma AG, Kedrion SpA, Mitsubishi Tanabe Pharma Corporation, Takeda, Baxter, Grifols, Hualan Bio and BPL, etc.

Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Blood Products Market Size 2017-2028
  2.1.2 Human Blood Products Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Human Blood Products Segment by Type
  2.2.1 Platelets
  2.2.2 Fresh Frozen Plasma
  2.2.3 Red Blood Cells
  2.2.4 White Blood Cells
  2.2.5 Others
2.3 Human Blood Products Market Size by Type
  2.3.1 Human Blood Products Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Human Blood Products Market Size Market Share by Type (2017-2022)
2.4 Human Blood Products Segment by Application
  2.4.1 Hospital
  2.4.2 Blood Station
  2.4.3 Others
2.5 Human Blood Products Market Size by Application
  2.5.1 Human Blood Products Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Human Blood Products Market Size Market Share by Application (2017-2022)

3 HUMAN BLOOD PRODUCTS MARKET SIZE BY PLAYER

3.1 Human Blood Products Market Size Market Share by Players
  3.1.1 Global Human Blood Products Revenue by Players (2020-2022)
  3.1.2 Global Human Blood Products Revenue Market Share by Players (2020-2022)
3.2 Global Human Blood Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HUMAN BLOOD PRODUCTS BY REGIONS

4.1 Human Blood Products Market Size by Regions (2017-2022)
4.2 Americas Human Blood Products Market Size Growth (2017-2022)
4.3 APAC Human Blood Products Market Size Growth (2017-2022)
4.4 Europe Human Blood Products Market Size Growth (2017-2022)
4.5 Middle East & Africa Human Blood Products Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Human Blood Products Market Size by Country (2017-2022)
5.2 Americas Human Blood Products Market Size by Type (2017-2022)
5.3 Americas Human Blood Products Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Human Blood Products Market Size by Region (2017-2022)
6.2 APAC Human Blood Products Market Size by Type (2017-2022)
6.3 APAC Human Blood Products Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Human Blood Products by Country (2017-2022)
7.2 Europe Human Blood Products Market Size by Type (2017-2022)
7.3 Europe Human Blood Products Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Blood Products by Region (2017-2022)
8.2 Middle East & Africa Human Blood Products Market Size by Type (2017-2022)
8.3 Middle East & Africa Human Blood Products Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HUMAN BLOOD PRODUCTS MARKET FORECAST

10.1 Global Human Blood Products Forecast by Regions (2023-2028)
  10.1.1 Global Human Blood Products Forecast by Regions (2023-2028)
  10.1.2 Americas Human Blood Products Forecast
  10.1.3 APAC Human Blood Products Forecast
  10.1.4 Europe Human Blood Products Forecast
  10.1.5 Middle East & Africa Human Blood Products Forecast
10.2 Americas Human Blood Products Forecast by Country (2023-2028)
  10.2.1 United States Human Blood Products Market Forecast
  10.2.2 Canada Human Blood Products Market Forecast
  10.2.3 Mexico Human Blood Products Market Forecast
  10.2.4 Brazil Human Blood Products Market Forecast
10.3 APAC Human Blood Products Forecast by Region (2023-2028)
  10.3.1 China Human Blood Products Market Forecast
  10.3.2 Japan Human Blood Products Market Forecast
  10.3.3 Korea Human Blood Products Market Forecast
  10.3.4 Southeast Asia Human Blood Products Market Forecast
  10.3.5 India Human Blood Products Market Forecast
  10.3.6 Australia Human Blood Products Market Forecast
10.4 Europe Human Blood Products Forecast by Country (2023-2028)
  10.4.1 Germany Human Blood Products Market Forecast
  10.4.2 France Human Blood Products Market Forecast
  10.4.3 UK Human Blood Products Market Forecast
  10.4.4 Italy Human Blood Products Market Forecast
  10.4.5 Russia Human Blood Products Market Forecast
10.5 Middle East & Africa Human Blood Products Forecast by Region (2023-2028)
  10.5.1 Egypt Human Blood Products Market Forecast
  10.5.2 South Africa Human Blood Products Market Forecast
  10.5.3 Israel Human Blood Products Market Forecast
  10.5.4 Turkey Human Blood Products Market Forecast
  10.5.5 GCC Countries Human Blood Products Market Forecast
10.6 Global Human Blood Products Forecast by Type (2023-2028)
10.7 Global Human Blood Products Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 CSL
  11.1.1 CSL Company Information
  11.1.2 CSL Human Blood Products Product Offered
  11.1.3 CSL Human Blood Products Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 CSL Main Business Overview
  11.1.5 CSL Latest Developments
11.2 Octapharma AG
  11.2.1 Octapharma AG Company Information
  11.2.2 Octapharma AG Human Blood Products Product Offered
  11.2.3 Octapharma AG Human Blood Products Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Octapharma AG Main Business Overview
  11.2.5 Octapharma AG Latest Developments
11.3 Kedrion SpA
  11.3.1 Kedrion SpA Company Information
  11.3.2 Kedrion SpA Human Blood Products Product Offered
  11.3.3 Kedrion SpA Human Blood Products Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Kedrion SpA Main Business Overview
  11.3.5 Kedrion SpA Latest Developments
11.4 Mitsubishi Tanabe Pharma Corporation
  11.4.1 Mitsubishi Tanabe Pharma Corporation Company Information
  11.4.2 Mitsubishi Tanabe Pharma Corporation Human Blood Products Product Offered
  11.4.3 Mitsubishi Tanabe Pharma Corporation Human Blood Products Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Mitsubishi Tanabe Pharma Corporation Main Business Overview
  11.4.5 Mitsubishi Tanabe Pharma Corporation Latest Developments
11.5 Takeda
  11.5.1 Takeda Company Information
  11.5.2 Takeda Human Blood Products Product Offered
  11.5.3 Takeda Human Blood Products Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Takeda Main Business Overview
  11.5.5 Takeda Latest Developments
11.6 Baxter
  11.6.1 Baxter Company Information
  11.6.2 Baxter Human Blood Products Product Offered
  11.6.3 Baxter Human Blood Products Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 Baxter Main Business Overview
  11.6.5 Baxter Latest Developments
11.7 Grifols
  11.7.1 Grifols Company Information
  11.7.2 Grifols Human Blood Products Product Offered
  11.7.3 Grifols Human Blood Products Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 Grifols Main Business Overview
  11.7.5 Grifols Latest Developments
11.8 Hualan Bio
  11.8.1 Hualan Bio Company Information
  11.8.2 Hualan Bio Human Blood Products Product Offered
  11.8.3 Hualan Bio Human Blood Products Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 Hualan Bio Main Business Overview
  11.8.5 Hualan Bio Latest Developments
11.9 BPL
  11.9.1 BPL Company Information
  11.9.2 BPL Human Blood Products Product Offered
  11.9.3 BPL Human Blood Products Revenue, Gross Margin and Market Share (2020-2022)
  11.9.4 BPL Main Business Overview
  11.9.5 BPL Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Human Blood Products Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Platelets
Table 3. Major Players of Fresh Frozen Plasma
Table 4. Major Players of Red Blood Cells
Table 5. Major Players of White Blood Cells
Table 6. Major Players of Others
Table 7. Human Blood Products Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Human Blood Products Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Human Blood Products Market Size Market Share by Type (2017-2022)
Table 10. Human Blood Products Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Human Blood Products Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Human Blood Products Market Size Market Share by Application (2017-2022)
Table 13. Global Human Blood Products Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Human Blood Products Revenue Market Share by Player (2020-2022)
Table 15. Human Blood Products Key Players Head office and Products Offered
Table 16. Human Blood Products Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Human Blood Products Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Human Blood Products Market Size Market Share by Regions (2017-2022)
Table 21. Americas Human Blood Products Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Human Blood Products Market Size Market Share by Country (2017-2022)
Table 23. Americas Human Blood Products Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Human Blood Products Market Size Market Share by Type (2017-2022)
Table 25. Americas Human Blood Products Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Human Blood Products Market Size Market Share by Application (2017-2022)
Table 27. APAC Human Blood Products Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Human Blood Products Market Size Market Share by Region (2017-2022)
Table 29. APAC Human Blood Products Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Human Blood Products Market Size Market Share by Type (2017-2022)
Table 31. APAC Human Blood Products Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Human Blood Products Market Size Market Share by Application (2017-2022)
Table 33. Europe Human Blood Products Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Human Blood Products Market Size Market Share by Country (2017-2022)
Table 35. Europe Human Blood Products Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Human Blood Products Market Size Market Share by Type (2017-2022)
Table 37. Europe Human Blood Products Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Human Blood Products Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Human Blood Products Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Human Blood Products Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Human Blood Products Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Human Blood Products Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Human Blood Products Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Human Blood Products Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Human Blood Products
Table 46. Key Market Challenges & Risks of Human Blood Products
Table 47. Key Industry Trends of Human Blood Products
Table 48. Global Human Blood Products Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Human Blood Products Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Human Blood Products Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Human Blood Products Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Human Blood Products Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Human Blood Products Market Size Market Share Forecast by Application (2023-2028)
Table 54. CSL Details, Company Type, Human Blood Products Area Served and Its Competitors
Table 55. CSL Human Blood Products Product Offered
Table 56. CSL Human Blood Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. CSL Main Business
Table 58. CSL Latest Developments
Table 59. Octapharma AG Details, Company Type, Human Blood Products Area Served and Its Competitors
Table 60. Octapharma AG Human Blood Products Product Offered
Table 61. Octapharma AG Main Business
Table 62. Octapharma AG Human Blood Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Octapharma AG Latest Developments
Table 64. Kedrion SpA Details, Company Type, Human Blood Products Area Served and Its Competitors
Table 65. Kedrion SpA Human Blood Products Product Offered
Table 66. Kedrion SpA Main Business
Table 67. Kedrion SpA Human Blood Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Kedrion SpA Latest Developments
Table 69. Mitsubishi Tanabe Pharma Corporation Details, Company Type, Human Blood Products Area Served and Its Competitors
Table 70. Mitsubishi Tanabe Pharma Corporation Human Blood Products Product Offered
Table 71. Mitsubishi Tanabe Pharma Corporation Main Business
Table 72. Mitsubishi Tanabe Pharma Corporation Human Blood Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Mitsubishi Tanabe Pharma Corporation Latest Developments
Table 74. Takeda Details, Company Type, Human Blood Products Area Served and Its Competitors
Table 75. Takeda Human Blood Products Product Offered
Table 76. Takeda Main Business
Table 77. Takeda Human Blood Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Takeda Latest Developments
Table 79. Baxter Details, Company Type, Human Blood Products Area Served and Its Competitors
Table 80. Baxter Human Blood Products Product Offered
Table 81. Baxter Main Business
Table 82. Baxter Human Blood Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Baxter Latest Developments
Table 84. Grifols Details, Company Type, Human Blood Products Area Served and Its Competitors
Table 85. Grifols Human Blood Products Product Offered
Table 86. Grifols Main Business
Table 87. Grifols Human Blood Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Grifols Latest Developments
Table 89. Hualan Bio Details, Company Type, Human Blood Products Area Served and Its Competitors
Table 90. Hualan Bio Human Blood Products Product Offered
Table 91. Hualan Bio Main Business
Table 92. Hualan Bio Human Blood Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Hualan Bio Latest Developments
Table 94. BPL Details, Company Type, Human Blood Products Area Served and Its Competitors
Table 95. BPL Human Blood Products Product Offered
Table 96. BPL Main Business
Table 97. BPL Human Blood Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. BPL Latest Developments

LIST OF FIGURES


LIST OF FIGURES

Figure 1. Human Blood Products Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Blood Products Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Human Blood Products Market Size Market Share by Type in 2021
Figure 7. Human Blood Products in Hospital
Figure 8. Global Human Blood Products Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Human Blood Products in Blood Station
Figure 10. Global Human Blood Products Market: Blood Station (2017-2022) & ($ Millions)
Figure 11. Human Blood Products in Others
Figure 12. Global Human Blood Products Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Human Blood Products Market Size Market Share by Application in 2021
Figure 14. Global Human Blood Products Revenue Market Share by Player in 2021
Figure 15. Global Human Blood Products Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Human Blood Products Market Size 2017-2022 ($ Millions)
Figure 17. APAC Human Blood Products Market Size 2017-2022 ($ Millions)
Figure 18. Europe Human Blood Products Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Human Blood Products Market Size 2017-2022 ($ Millions)
Figure 20. Americas Human Blood Products Value Market Share by Country in 2021
Figure 21. Americas Human Blood Products Consumption Market Share by Type in 2021
Figure 22. Americas Human Blood Products Market Size Market Share by Application in 2021
Figure 23. United States Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Human Blood Products Market Size Market Share by Region in 2021
Figure 28. APAC Human Blood Products Market Size Market Share by Application in 2021
Figure 29. China Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Human Blood Products Market Size Market Share by Country in 2021
Figure 36. Europe Human Blood Products Market Size Market Share by Type in 2021
Figure 37. Europe Human Blood Products Market Size Market Share by Application in 2021
Figure 38. Germany Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Human Blood Products Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Human Blood Products Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Human Blood Products Market Size Market Share by Application in 2021
Figure 46. Egypt Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Human Blood Products Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 52. APAC Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 53. Europe Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 55. United States Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 56. Canada Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 59. China Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 60. Japan Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 61. Korea Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 63. India Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 64. Australia Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 65. Germany Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 66. France Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 67. UK Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 68. Italy Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 69. Russia Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 70. Spain Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 73. Israel Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Human Blood Products Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Human Blood Products Market Size 2023-2028 ($ Millions)


More Publications